SCHEMBL5693095

SCHEMBL5693095

NS(=O)(=O)c1ccc(C(F)(F)F)c(-c2nccs2)c1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
LOXL2 Q9Y4K0 1/20 0.31
PDPK1 O15530 1/20 0.31
SYK P43405 1/20 0.31
KIF11 P52732 1/20 0.31
AR P10275 2/20 0.31
ABCC9 O60706 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9953159 0.70 ALDH1A1 (0.40) TDP1ALDH1A1LOXL2PDPK1
SCHEMBL10873651 0.69 ALDH1A1 (0.43) TDP1ALDH1A1ADORA2AADORA1LOXL2
SCHEMBL16540008 0.67 PDPK1 (0.49) CA12CA1CA2CA4CA6
SCHEMBL8770178 0.65 CA2 (0.41) CA12CA1CA2CA4CA6
SCHEMBL29608350 0.65 ADORA2A (0.47) CA12CA1CA2CA4CA6
SCHEMBL1093747 0.65 ADORA2A (0.47) CA12CA1CA2CA4CA6
SCHEMBL12503022 0.65 PDPK1 (0.43) TDP1ALDH1A1PDPK1
SCHEMBL3838065 0.65 ALDH1A1 (0.39) TDP1ALDH1A1CA12CA1CA2
SCHEMBL30130504 0.65 ALDH1A1 (0.39) TDP1ALDH1A1CA12CA1CA2
SCHEMBL28816427 0.65 LOXL2 (0.45) CA2CA9ADORA2AADORA1LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638553-A1 NEW USE I BIOVITRUM AB (SE) 2006-03-29 EP claimed
WO-2004112784-A1 NEW USE I BIOVITRUM AB (SE) 2004-12-29 WO claimed
WO-2019075394-A1 COMPOUNDS FOR TREATMENT OF EMOTIONAL/PSYCHOLOGICAL SYMPTOMS IN FRAGILE X SYNDROME VANDERKLISH PETER (US) 2019-04-18 WO disclosed
EP-1461325-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2004-09-29 EP disclosed
WO-2003043999-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2003-05-30 WO disclosed